Trial Profile
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Idiopathic Cough
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Rolapitant (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 26 Jun 2014 New trial record